Clinical Trial

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Study acronym: VALOR
Recruiting
View on ClinicalTrials.gov →
Summary
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-07-11; most recent amendment 2026-02-19.
Status change: Not Yet Recruiting → Recruiting 2023-11-03
Trial Details
NCT Number NCT05953090
Lead Sponsor Stratpharma AG
Conditions Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)
Enrollment 2,000 participants
Start Date 2023-10-30
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-20